![]() |
市場調査レポート
商品コード
1780231
組織バンク市場規模、シェア、成長分析、製品別、組織タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年Tissue Banking Market Size, Share, and Growth Analysis, By Product (Equipment, Cryopreservation Equipment), By Tissue Type (Heart Valves, Cornea), By Application, By End-User, By Region - Industry Forecast 2025-2032 |
||||||
|
組織バンク市場規模、シェア、成長分析、製品別、組織タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年 |
出版日: 2025年07月26日
発行: SkyQuest
ページ情報: 英文 187 Pages
納期: 3~5営業日
|
組織バンクの世界市場規模は、2023年に43億米ドルと評価され、2024年の45億3,000万米ドルから2032年には68億4,000万米ドルに成長すると予測され、予測期間(2025-2032年)のCAGRは5.3%で成長しています。
世界組織バンク市場は、再生医療需要の増加、慢性疾患患者の増加、組織保存技術の進歩に牽引され、力強い成長を遂げています。老年人口の拡大や組織提供に関する意識の高まりが市場拡大に大きく寄与しています。さらに、政府の取り組みやヘルスケアインフラへの投資が、世界の近代的なバイオバンク施設の開発を支えています。北米は現在、高い導入率と有利な規制の枠組みにより市場を独占しているが、アジア太平洋は医療支出の増加とドナー意識向上プログラムに後押しされ、有利な地域として浮上しています。
Global Tissue Banking Market size was valued at USD 4.3 Billion in 2023 poised to grow from USD 4.53 Billion in 2024 to USD 6.84 Billion by 2032, growing at a CAGR of 5.3% in the forecast period (2025-2032).
The Global Tissue Banking Market is experiencing robust growth, driven by increasing demand for regenerative medicine, rising cases of chronic diseases, and advancements in tissue preservation technologies. The expanding geriatric population and growing awareness about tissue donation are significantly contributing to market expansion. Additionally, government initiatives and investments in healthcare infrastructure are supporting the development of modern biobanking facilities worldwide. North America currently dominates the market due to high adoption rates and favorable regulatory frameworks, while Asia-Pacific is emerging as a lucrative region, fueled by rising healthcare spending and improved donor awareness programs.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tissue Banking Market Segments Analysis
The global tissue banking market is segmented based on application, tissue bank, end use, and region. In terms of application, the market is grouped into regenerative medicine, drug discovery, tissue engineering, and transplantation. Based on the tissue bank, the market is trifurcated into cell bank, organ bank, and tissue bank. Based on end use, the market is segmented into hospitals, research institutions, and pharmaceutical companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.
Driver of the Global Tissue Banking Market
A prominent catalyst for the expansion of the global tissue banking market is the increasing need for regenerative medicine. The growing interest in stem cell therapies, tissue transplants, and customized treatments has led to a heightened demand for essential biological materials stored in tissue banks. This surge in demand is driving advancements in tissue preservation technologies and the development of biobanking infrastructures around the world. As healthcare continues to evolve towards more innovative and personalized approaches, the role of tissue banking becomes increasingly vital, facilitating the availability of crucial resources for researchers and clinicians alike.
Restraints in the Global Tissue Banking Market
The expansion of the global tissue banking market faces significant challenges due to ethical and legal issues related to tissue donation, consent, and privacy. The presence of strict regulations and diverse laws across different regions complicates the processes of tissue collection and utilization. This complexity poses difficulties for tissue banks in implementing uniform practices, as they must navigate and comply with local ethical requirements. Consequently, these constraints can limit the availability of tissues for research and therapeutic applications, ultimately hindering the growth and development of this vital sector in healthcare. Maintaining a balance between ethical considerations and operational efficiency remains a critical concern.
Market Trends of the Global Tissue Banking Market
The global tissue banking market is experiencing a notable trend characterized by the increased adoption of automated biobanking systems. This shift towards automation enhances operational efficiency and significantly minimizes human error, resulting in higher preservation quality of biological samples. As institutions strive for innovation and streamlined processes, advanced technologies such as automated tissue collection, storage, and analysis systems are becoming integral to tissue banking operations. This trend not only boosts the reliability of sample handling but also meets the growing demand from research and clinical applications, ultimately contributing to the market's expansion and evolving landscape as stakeholders prioritize precision and efficiency in tissue preservation.